Adrian (“Ad”) Rawcliffe is Senior Vice President, Finance North America Pharmaceuticals.
Mr. Rawcliffe joined GSK in 1998 in London and moved to North Carolina in 1999 and Philadelphia in 2002. He has worked in a variety of finance and business development roles including most recently SVP Worldwide Business Development and R&D Finance where he was responsible for all Pharmaceuticals R&D business development activities for GSK including co-development, in-licensing, options based drug discovery collaborations, product acquisition, co-promotion / co-marketing arrangements, and R&D driven M&A activity as well as financial management and control of Pharmaceuticals R&D.
Immediately prior to becoming SVP Worldwide Business Development, Ad was Managing Partner and President, of SR One Ltd, GSK’s venture-capital business.
Ad qualified as a Chartered Accountant with Coopers and Lybrand in 1996 and worked in their audit and forensic accounting groups in the UK. He holds a BSc degree in Natural Sciences from the University of Durham, UK.
